Target intelligence / Profile preview

Multiple paracrine pathways

Molecular classification
Other
01

Overview

Multiple paracrine pathways refer to the complex network of local cell-to-cell communication where cells secrete signaling molecules into the immediate extracellular environment to influence the behavior of neighboring cells (Source: Nature Education, 2014). This term does not represent a single molecular target, such as a specific receptor or enzyme, but rather a collective physiological process involving various ligands like cytokines, chemokines, and growth factors. In therapeutic contexts, particularly in regenerative medicine and oncology, the term is frequently used to describe the mechanism by which stem cells or tumor cells modulate their microenvironment to promote tissue repair or disease progression (Source: PubMed, PMID: 30631533). Because it encompasses a wide array of distinct molecular interactions rather than a discrete protein, it is considered a physiological system or mechanism of action rather than a specific druggable target. Consequently, drug development focusing on these pathways usually involves multi-component biologics or cell-based therapies designed to mimic or inhibit the broad secretome of a cell (Source: NIH, StatPearls, 2023).

Other names
Paracrine signalingLocal cell-to-cell signalingSecretome-mediated signalingParacrine factors
02

Mechanism of action

Modulation of the cellular microenvironment through the secretion of diverse signaling molecules (ligands) that bind to receptors on adjacent cells to elicit biological responses.

03

Biological functions

Signal transductionCell proliferationAngiogenesisImmune responseTissue repairApoptosis
04

Disease associations

CancerCardiovascular diseaseInflammationNeurodegenerative diseaseWound healing
05

Safety considerations

Pleiotropic effects leading to off-target systemic responsesPotential for promoting tumor angiogenesis or metastasisDifficulty in controlling the dosage and duration of multi-component signalingRisk of unwanted inflammatory responses
06

Interacting drugs

Mesenchymal stem cells

3 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF)Fibroblast growth factor (FGF)Interleukin-6 (IL-6)Transforming growth factor beta (TGF-beta)

Beyond the preview

Go deeper on Multiple paracrine pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple paracrine pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call